1596 related articles for article (PubMed ID: 7701526)
1. Comparison of antinuclear antibody and other immunohematological profiles among primary Sjögren's syndrome, secondary Sjögren's syndrome associated with rheumatoid arthritis or systemic lupus erythematosus, and corresponding systemic disease.
Ichikawa Y; Takaya M; Shimizu H; Uchiyama M; Moriuchi J; Morita K; Hoshina Y; Horiki T
Tokai J Exp Clin Med; 1993 Dec; 18(3-6):133-8. PubMed ID: 7701526
[TBL] [Abstract][Full Text] [Related]
2. IgA and IgG autoantibodies against alpha-fodrin as markers for Sjögren's syndrome. Systemic lupus erythematosus.
Witte T; Matthias T; Arnett FC; Peter HH; Hartung K; Sachse C; Wigand R; Braner A; Kalden JR; Lakomek HJ; Schmidt RE
J Rheumatol; 2000 Nov; 27(11):2617-20. PubMed ID: 11093442
[TBL] [Abstract][Full Text] [Related]
3. The relationship between anti-Ro (SS-A) antibody-positive Sjögren's syndrome and anti-Ro (SS-A) antibody-positive lupus erythematosus.
Provost TT; Talal N; Harley JB; Reichlin M; Alexander E
Arch Dermatol; 1988 Jan; 124(1):63-71. PubMed ID: 3257371
[TBL] [Abstract][Full Text] [Related]
4. Profiles of antibodies to histones, DNA and IgG in patients with systemic rheumatic diseases determined by ELISA.
Gripenberg M; Helve T; Kurki P
J Rheumatol; 1985 Oct; 12(5):934-9. PubMed ID: 3878880
[TBL] [Abstract][Full Text] [Related]
5. Symptomatic secondary Sjögren's syndrome in patients with systemic lupus erythematosus (SLE). Relation to anti-SS-A and anti-SS-B autoantibodies.
Jonsson H; Nived O; Sturfelt G; Norberg R
Scand J Rheumatol Suppl; 1986; 61():166-9. PubMed ID: 3495873
[TBL] [Abstract][Full Text] [Related]
6. Anti-agalactosyl IgG antibodies and isotype profiles of rheumatoid factors in Sjögren's syndrome and rheumatoid arthritis.
Ichikawa Y; Yamada C; Horiki T; Hoshina Y; Uchiyama M; Yamada Y; Toumatu J
Clin Exp Rheumatol; 1998; 16(6):709-15. PubMed ID: 9844764
[TBL] [Abstract][Full Text] [Related]
7. Systemic autoimmune diseases in patients with hepatitis C virus infection: characterization of 1020 cases (The HISPAMEC Registry).
Ramos-Casals M; Muñoz S; Medina F; Jara LJ; Rosas J; Calvo-Alen J; Brito-Zerón P; Forns X; Sánchez-Tapias JM;
J Rheumatol; 2009 Jul; 36(7):1442-8. PubMed ID: 19369460
[TBL] [Abstract][Full Text] [Related]
8. Ro(SSA) and La(SSB) antibodies in the clinical spectrum of Sjögren's syndrome.
Alexander EL; Hirsch TJ; Arnett FC; Provost TT; Stevens MB
J Rheumatol; 1982; 9(2):239-46. PubMed ID: 7097683
[TBL] [Abstract][Full Text] [Related]
9. Genetic studies of anti-Ro (SSA) antibodies in families with rheumatoid arthritis.
Tishler M; Moutsopoulos HM; Yaron M
J Rheumatol; 1992 Feb; 19(2):234-6. PubMed ID: 1629820
[TBL] [Abstract][Full Text] [Related]
10. Association between HLA-DRB1*15 and secondary Sjögren's syndrome in patients with rheumatoid arthritis.
Mattey DL; González-Gay MA; Hajeer AH; Dababneh A; Thomson W; García-Porrúa C; Ollier WE
J Rheumatol; 2000 Nov; 27(11):2611-6. PubMed ID: 11093441
[TBL] [Abstract][Full Text] [Related]
11. [The clinical significance of disorders of humoral immunity in Sjögren's disease and syndrome].
Kirtava ZZ
Revmatologiia (Mosk); 1990; (4):35-41. PubMed ID: 2075353
[TBL] [Abstract][Full Text] [Related]
12. Anti-52 kDa Ro(SSA) autoantibodies in different autoimmune diseases preferentially recognize epitopes on the central region of the antigen.
Dorner T; Feist E; Wagenmann A; Kato T; Yamamoto K; Nishioka K; Burmester GR; Hiepe F
J Rheumatol; 1996 Mar; 23(3):462-8. PubMed ID: 8832984
[TBL] [Abstract][Full Text] [Related]
13. Sjögren's syndrome in systemic lupus erythematosus.
Andonopoulos AP; Skopouli FN; Dimou GS; Drosos AA; Moutsopoulos HM
J Rheumatol; 1990 Feb; 17(2):201-4. PubMed ID: 2319519
[TBL] [Abstract][Full Text] [Related]
14. Determination of the subset of Sjogren's syndrome with articular manifestations by anticyclic citrullinated peptide antibodies.
Iwamoto N; Kawakami A; Tamai M; Fujikawa K; Arima K; Aramaki T; Kawashiri S; Ichinose K; Kamachi M; Nakamura H; Origuchi T; Ida H; Eguchi K
J Rheumatol; 2009 Jan; 36(1):113-5. PubMed ID: 19132785
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic significance of immunohistological skin examination in patients with primary Sjögren's syndrome and other chronic inflammatory connective tissue diseases.
Oxholm P; Oxholm A; Manthorpe R
Scand J Rheumatol Suppl; 1986; 61():173-6. PubMed ID: 3296145
[TBL] [Abstract][Full Text] [Related]
16. [Specific antibodies of soluble nuclear antigens in autoimmune vasculitis].
Weill BJ; Job-Deslandre C; Menkès CJ; Amor B
Rev Rhum Mal Osteoartic; 1987 Jun; 54(6):453-6. PubMed ID: 3303286
[TBL] [Abstract][Full Text] [Related]
17. [Isotypes and subtypes of anti-SS-A and/or SS-B antibodies in different subgroups of Sjögren's syndrome].
Takaya M; Ichikawa Y
Nihon Rinsho; 1995 Oct; 53(10):2429-33. PubMed ID: 8531350
[TBL] [Abstract][Full Text] [Related]
18. Antibodies to gliadin, gluten and reticulin glycoprotein in rheumatic diseases: elevated levels in Sjögren's syndrome.
Teppo AM; Maury CP
Clin Exp Immunol; 1984 Jul; 57(1):73-8. PubMed ID: 6378463
[TBL] [Abstract][Full Text] [Related]
19. [Antibodies against soluble nuclear antigens of the SS-A or SS-B type. Significance in systemic lupus erythematosis (author's transl)].
Meyer O; Haim T
Nouv Presse Med; 1981 Jun; 10(26):2179-84. PubMed ID: 6973748
[TBL] [Abstract][Full Text] [Related]
20. Presence of antinucleosome autoantibodies in a restricted set of connective tissue diseases: antinucleosome antibodies of the IgG3 subclass are markers of renal pathogenicity in systemic lupus erythematosus.
Amoura Z; Koutouzov S; Chabre H; Cacoub P; Amoura I; Musset L; Bach JF; Piette JC
Arthritis Rheum; 2000 Jan; 43(1):76-84. PubMed ID: 10643702
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]